BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30513772)

  • 1. Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients.
    Hermida-Prado F; Menéndez ST; Albornoz-Afanasiev P; Granda-Diaz R; Álvarez-Teijeiro S; Villaronga MÁ; Allonca E; Alonso-Durán L; León X; Alemany L; Mena M; Del-Rio-Ibisate N; Astudillo A; Rodríguez R; Rodrigo JP; García-Pedrero JM
    J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30513772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.
    Rodrigo JP; Menéndez ST; Hermida-Prado F; Álvarez-Teijeiro S; Villaronga MÁ; Alonso-Durán L; Vallina A; Martínez-Camblor P; Astudillo A; Suárez C; María García-Pedrero J
    Sci Rep; 2015 Oct; 5():15698. PubMed ID: 26498851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
    Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
    Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.
    Dedes KJ; Lopez-Garcia MA; Geyer FC; Lambros MB; Savage K; Vatcheva R; Wilkerson P; Wetterskog D; Lacroix-Triki M; Natrajan R; Reis-Filho JS
    Breast Cancer Res Treat; 2010 Dec; 124(3):653-66. PubMed ID: 20213079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas and Paired Normal Mucosae Reveals Cyclin D1 Deregulation and Compensatory Effect of Cyclin D2.
    Novotný J; Bandúrová V; Strnad H; Chovanec M; Hradilová M; Šáchová J; Šteffl M; Grušanović J; Kodet R; Pačes V; Lacina L; Smetana K; Plzák J; Kolář M; Vomastek T
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32224897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.
    Ruiz C; Martins JR; Rudin F; Schneider S; Dietsche T; Fischer CA; Tornillo L; Terracciano LM; Schreiber R; Bubendorf L; Kunzelmann K
    PLoS One; 2012; 7(8):e43265. PubMed ID: 22912841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours.
    Ragin CC; Taioli E; Weissfeld JL; White JS; Rossie KM; Modugno F; Gollin SM
    Br J Cancer; 2006 Nov; 95(10):1432-8. PubMed ID: 17003776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
    van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
    Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma.
    Tian G; Fu Y; Zhang D; Li J; Zhang Z; Yang X
    Cancer Cell Int; 2021 Mar; 21(1):167. PubMed ID: 33712015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
    Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
    Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
    Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C
    J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.
    Ayoub C; Wasylyk C; Li Y; Thomas E; Marisa L; Robé A; Roux M; Abecassis J; de Reyniès A; Wasylyk B
    Br J Cancer; 2010 Aug; 103(5):715-26. PubMed ID: 20664600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy number gain of 11q13.3 genes associates with pathological stage in hypopharyngeal squamous cell carcinoma.
    Pattle SB; Utjesanovic N; Togo A; Wells L; Conn B; Monaghan H; Junor E; Johannessen I; Cuschieri K; Talbot S
    Genes Chromosomes Cancer; 2017 Mar; 56(3):185-198. PubMed ID: 27750372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS1 as a Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas.
    Guo M; Zhang L; Wang H; Zhou Q; Zhu X; Fu X; Yang J; Liu S; Guo D; Zhang B
    Curr Issues Mol Biol; 2023 Jun; 45(7):5598-5612. PubMed ID: 37504269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
    Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas.
    Kopczyńska M; Kolenda T; Guglas K; Sobocińska J; Teresiak A; Bliźniak R; Mackiewicz A; Mackiewicz J; Lamperska K
    Diagnostics (Basel); 2020 Sep; 10(10):. PubMed ID: 32998396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.